LOS ANGELES, May 6 - Teva Pharmaceutical Industries Ltd has sued AstraZeneca Plc asking for a declaratory judgment on remaining Nexium patents, AstraZeneca said on Tuesday.
The Anglo-Swedish drugmaker had sued Israel-based Teva for infringement of some patents covering the ulcer pill and Teva is asking the court to require AstraZeneca to either sue it on these patents, or declare the patents are non-infringed or invalid, Sanford C. Bernstein analyst Ronny Gal said in a research note.
"This is part of Teva's strategy to trigger the exclusivity of Nexium," he said.
The details can be read here.
No comments:
Post a Comment